Inventor
PETTEGREW JAY W
US11 patents
⚠️ This page may combine multiple inventors who share the name “PETTEGREW JAY W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PETTEGREW JAY W
6 patentsUS7815894B2Oct 19, 2010
Compounds, compositions and methods for medical imaging of neuropsychiatric disorders
PETTEGREW JAY W2 citations60
US7632662B2Dec 15, 2009
Compounds, compositions and methods for producing antioxidants from carnitine
PETTEGREW JAY W2 citations60
US7700074B2Apr 20, 2010
Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
PETTEGREW JAY W5 citations59
US7407778B2Aug 5, 2008
Compounds, compositions and methods for treating neuropsychiatric disorders
PETTEGREW JAY W5 citations54
US8329142B2Dec 11, 2012
Compounds, compositions and methods for medical imaging of Parkinson's disease
PETTEGREW JAY W0 citations49
US8894973B2Nov 25, 2014
Method and system for differential diagnosis of chronic schizophrenia and chronic alcoholism
PETTEGREW JAY W0 citations48
UNIV PITTSBURGH
4 patentsUS6168776B1Jan 2, 2001
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
UNIV PITTSBURGH120 citations98
US6417178B1Jul 9, 2002
Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
UNIV PITTSBURGH148 citations97
US6133259AOct 17, 2000
Alkyl, alkenyl and alkynyl chrysamine G derivatives for inhibition of cell degeneration and toxicity associated with amyloid deposition
UNIV PITTSBURGH42 citations95
US6114175ASep 5, 2000
Compound for the antemortem diagnosis of Alzheimer's Disease and in vivo imaging and prevention of amyloid deposition
UNIV PITTSBURGH72 citations95